News

First PFAS “Forever Chemicals” Consumer-Initiated Blood Test With Physician Consult Launches on questhealth.com

Directed at individuals who may be at risk of elevated PFAS exposure, the new test detects and measures PFAS identified…

2 years ago

Machinify Debuts Healthcare Industry’s Most Comprehensive Application Suite, Powered by the Combination of AI and Deep Clinical Expertise, to Save Billions in Administrative Costs

Company helps four out of the top 10 insurance companies automate healthcare administrationPALO ALTO, Calif.--(BUSINESS WIRE)--#AIHealthcareRevolution--Machinify, the company transforming healthcare…

2 years ago

MentalHealth.com Appoints Brian Trisler, Co-Founder of A Place for Mom, to Venture Advisory Team

SAN FRANCISCO, CA / ACCESSWIRE / March 4, 2024 / Leading health technology company MentalHealth.com is pleased to announce the…

2 years ago

LivaNova to Present at the Barclays Global Healthcare Conference

LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in…

2 years ago

Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership

BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the…

2 years ago

CPSI, Rebranded as TruBridge, Inc., Rings Opening Bell at NASDAQ to Announce New Trading Symbol TBRG

MOBILE, Ala.--(BUSINESS WIRE)--The Company formerly known as CPSI has officially rebranded and changed its name to TruBridge, Inc. (“TruBridge”), effective…

2 years ago

Koneksa Appoints Dr. Jessie Bakker as Vice President of Clinical Development

NEW YORK--(BUSINESS WIRE)--#biotech--Koneksa, the evidence-based digital biomarkers company, today announced the appointment of Jessie Bakker, M.S., Ph.D., as Vice President…

2 years ago

LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

44 ALLY® Adaptive Cataract Treatment Systems were placed in 2023, significantly exceeding the target of 30, increasing the ALLY installed…

2 years ago

Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan

SEATTLE, WA / ACCESSWIRE / March 4, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that…

2 years ago

Omaha Healthcare Company Recognized for Brand Launch and New Environmental Graphics

Omaha-based Fusion was awarded for two large marketing projects that were unveiled in late 2023.OMAHA, NE / ACCESSWIRE / March…

2 years ago